Hoth Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Hoth Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • Hoth Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.65M, a 3.68% increase year-over-year.
  • Hoth Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$7.49M, a 25.1% increase year-over-year.
  • Hoth Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$7.69M, a 30.5% increase from 2022.
  • Hoth Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$11.1M, a 21.5% increase from 2021.
  • Hoth Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$14.1M, a 93.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$7.69M +$3.37M +30.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$11.1M +$3.04M +21.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$14.1M -$6.8M -93.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$7.3M +$413K +5.35% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 -$7.71M -$5.22M -209% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 -$2.5M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.